Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in North America, Europe and Israel or involving organisations from these countries.

Total search results: 5213 | Ordered by Date (descending)
1 2 3 ... 51 52 53  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Anjarium Biosciences–Abingworth: investment, 202109 financing round Series A totalling CHF55.5m incl co-lead investor Abingworth 2021-09-16
Anjarium Biosciences–Citadel: investment, 202109 financing round Series A totalling CHF55.5m incl co-investor Surveyor Capital 2021-09-16
Anjarium Biosciences–Huntsworth: public relations, 202109 service existent by Medistrava Consulting 2021-09-16
Anjarium Biosciences–Omega Funds: investment, 202109 financing round Series A totalling CHF55.5m incl co-investor Omega Funds 2021-09-16
Anjarium Biosciences–Pfizer: investment, 202109 financing round Series A totalling CHF55.5m incl co-investor Pfizer Ventures 2021-09-16
Anjarium Biosciences–SEVERAL: investment, 202109 financing round Series A CHF55.5m ($61m) co-led by Abingworth + Gimv 2021-09-16
Touchlight–Bridford Group: investment, 202109 financing round extension £50m incl co-lead investor Bridford Investments Ltd 2021-09-15
Touchlight–Novator Partners: investment, 202109 financing round extension £50m incl co-lead investor Novator Partners 2021-09-15
Touchlight–SEVERAL: investment, 202109 financing round extension £50m bringing total round to £92m led by Bridford + Novator 2021-09-15
TreeFrog Therapeutics–SEVERAL: investment, 202109 financing round Series B $75m (€64m) led by Bpifrance Large Venture 2021-09-13
Boehringer–Twist Bioscience: antibody drug discovery, 202109– collab using Twist Biopharma antibody phage display libraries against Boehringer targets 2021-09-09
TIB Molbiol–Roche: investment, 202109– acquisition 100% of TIB Mobiol Group by Roche SIGNED 2021-09-09
EnteroBiotix–Scius Communications: public relations, 202109 supply service existent by Scius Communications 2021-09-07
EnteroBiotix–SEVERAL: investment, 202109 financing round Series A £15.5m ($21.5m) led by Thairm Bio 2021-09-07
Owlstone–Horizons Ventures: investment, 202109 financing round Series D totalling $58m incl existing + lead investor Horizons Ventures 2021-09-07
Owlstone–SEVERAL: investment, 202109 financing round Series D $58m of Owlstone Medical led by existing investor Horizons Ventures 2021-09-07
Ascendis Pharma–SEVERAL: investment, 202108– public offering $400m + up to $60m of ADSs 2021-08-31
Tissium–Cathay Capital: investment, 202108 financing round Series C totalling €50m incl new + co-lead investor Cathay Health 2021-08-31
Tissium–SEVERAL: investment, 202108 financing round Series C €50m co-led by Cathay Health + Sofinnova Partners 2021-08-31
Tissium–Sofinnova: investment, 202108 financing round Series C totalling €50m incl existing + co-lead investor Sofinnova Partners 2021-08-31
Laronde–Flagship Pioneering: investment, 202108 financing round Series B totalling $440m incl founding investor Flagship Pioneering 2021-08-30
Laronde–SEVERAL: investment, 202108 financing round Series B $440m with founding investor Flagship Pioneering 2021-08-30
Lynk Pharmaceuticals–SEVERAL: investment, 202108 financing round $50m led by Lilly Asia Ventures 2021-08-27
HealthCare Royalty–ADC Therapeutics: antibody-drug conjugates, 202108 acquisition $225m upfront + $100m milestones royalty rights to Zynlonta + Cami 2021-08-26
Cardior Pharmaceuticals–BMS: investment, 202108 financing round Series B totalling €64m incl existing + co-investor BMS 2021-08-25
Cardior Pharmaceuticals–High-Tech Gründerfonds: investment, 202108 financing round Series B totalling €64m incl existing + co-investor HTGF 2021-08-25
Cardior Pharmaceuticals–SEVERAL: investment, 202108 financing round Series B €64m led by new investor Inkef Capital 2021-08-25
DiCE Molecules–1AB Media: public relations, 202108 service existent by 1AB Media 2021-08-24
DiCE Molecules–RA Capital: investment, 202108 financing round Series C-1 totalling $60m incl co-lead investor RA Capital Management 2021-08-24
DiCE Molecules–Sands Capital: investment, 202108 financing round Series C-1 totalling $60m incl co-lead investor Sands Capital 2021-08-24
DiCE Molecules–SEVERAL: investment, 202108 financing round Series C-1 $60m co-led by RA Capital + Sands Capital 2021-08-24
Jnana Therapeutics–SEVERAL: investment, 202108 financing round Series B $50m led by RA Capital + incl all exising investors 2021-08-18
Ranok Therapeutics–SEVERAL: investment, 202108 financing round Series B $40m co-led by Lapam Capital + Shanghai Healthcare Capital 2021-08-18
Vigil Neuroscience–SEVERAL: investment, 202108 financing round Series B $90m led by new investor Vida Ventures 2021-08-18
Beckley Psytech–Adage Capital: investment, 202108 financing round Series B totalling $80m incl co-investor Adage Capital Management LP 2021-08-16
Beckley Psytech–Bicycle Day Ventures: investment, 202108 financing round Series B totalling $80m incl existing + co-investor Bicycle Day Ventures 2021-08-16
Beckley Psytech–Delphi VC: investment, 202108 financing round Series B totalling $80m incl co-investor Delphi VC 2021-08-16
Beckley Psytech–FTI Consulting: public relations, 202108 service existent by FTI Consulting 2021-08-16
Beckley Psytech–Integrated VC: investment, 202108 financing round Series B totalling $80m incl lead investor Integrated 2021-08-16
Beckley Psytech–Leafy Tunnel: investment, 202108 financing round Series B totalling $80m incl co-investor Leafy Tunnel 2021-08-16
Beckley Psytech–LifeSci: public relations, 202108 service existent LifeSci Advisors is investor relations contact 2021-08-16
Beckley Psytech–Negev Capital: investment, 202108 financing round Series B totalling $80m incl co-investor Negev Capital 2021-08-16
Beckley Psytech–Palo Santo: investment, 202108 financing round Series B totalling $80m incl co-investor Palo Santo 2021-08-16
Beckley Psytech–Prime Movers Lab: investment, 202108 financing round Series B totalling $80m incl co-investor Prime Movers Lab 2021-08-16
Beckley Psytech–SEVERAL: investment, 202108 financing round Series B $80m (£58m) led by Integrated VC 2021-08-16
Ultromics–Alphabet: investment, 202108 financing round Series B totalling $33m incl new + co-investor GV 2021-08-16
Ultromics–BCBSA: investment, 202108 financing round Series B totalling $33m incl new + lead investor Blue Venture Fund 2021-08-16
Ultromics–SEVERAL: investment, 202108 financing round Series B $33m led by new investor Blue Venture Fund 2021-08-16
Ultromics–UnitedHealth: investment, 202108 financing round Series B totalling $33m incl new + co-investor Optum Ventures 2021-08-16
Ultromics–Univ Oxford: investment, 202108 financing round Series B totalling $33m incl existing + co-investor OSI 2021-08-16
Bayer–Berkeley Lights: plant research, 202108 collab multi-year €na RnD seeds and traits using Berkeley Lights Platform 2021-08-11
Visus Therapeutics–Life Sciences Partners: investment, 202108 financing round totalling $20m in preferred stock incl new + lead investor LSP 2021-08-10
Visus Therapeutics–SEVERAL: investment, 202108 financing round $20m in preferred stock led by new investor LSP 2021-08-10
OncXerna Therapeutics–Qiagen: molecular companion diagnostics, 202108– collab developm Xerna TME panel as NGS CDx for navicixizumab 2021-08-09
Qiagen–OncXerna Therapeutics: molecular companion diagnostics, 202108– license non-excl to Xerna TME panel as NGS CDx for Qiagen 2021-08-09
PepGen–LifeSci: public relations, 202108 service existent by LifeSci Communications 2021-08-05
PepGen–SEVERAL: investment, 202108 crossover financing round $112.5m with existing + new investors 2021-08-05
Vividion Therapeutics–Bayer: investment, 202108– acquisition $1.5b upfront + $500k milestones ANNOUNCED 2021-08-05
Sonoma Biotherapeutics–SEVERAL: investment, 202108 financing round Series B $265m led by Ally Bridge Group 2021-08-04
Circulomics–Pacific Biosciences: investment, 202108 acquisition €na of Circulomics by PacBio 2021-08-03
Engrail Therapeutics–Nan Fung: investment, 202108 financing round Series A extension totalling $32m inkl Alt- + Leadinvestor NFLS 2021-08-03
Engrail Therapeutics–SEVERAL: investment, 202108 financing round Series A extension $32m bringing total round to $64m led by NFLS 2021-08-03
Mestag Therapeutics–Alphabet: investment, 202108 seed financing round extension totalling $34m incl new + co-investor GV 2021-08-03
Mestag Therapeutics–Forbion: investment, 202108 seed financing round extension totalling $34m incl new + lead investor Forbion 2021-08-03
Mestag Therapeutics–JnJ: investment, 202108 seed financing round extension totalling $34m incl existing + co-investor JnJ Innovation JJDC Inc 2021-08-03
Mestag Therapeutics–Northpond Ventures: investment, 202108 seed financing round extension totalling $34m incl new + co-investor Northpond Ventures 2021-08-03
Mestag Therapeutics–SEVERAL: investment, 202108 seed financing round extension $34m led by Forbion bringing total seed round to $45m 2021-08-03
Mestag Therapeutics–SV Health Investors: investment, 202108 seed financing round extension totalling $34m incl existing + co-investor SVHI 2021-08-03
Translate Bio–Sanofi: investment, 202108– cash tender offer $3.2b at $38/share ANNOUNCED 2021-08-03
Evotec–SEVERAL: investment, 202108– proposed offering of ADSs via secondary US listing at Nasdaq Global Select Market FILED 2021-08-02
T-Knife–SEVERAL: investment, 202108 financing round Series B $110m led by new investor Fidelity Management and Research 2021-08-02
Topas Therapeutics–Epidarex Capital: investment, 202107 financing round Series B extension €18m incl existing investor Epidarex Capital 2021-07-29
Topas Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €18m bringing total round to €40m incl all existing investors 2021-07-29
Artios Pharma–Omega Funds: investment, 202107 financing round Series C totalling £110m ($153m) incl new + co-lead investor Omega Funds 2021-07-27
Artios Pharma–SEVERAL: investment, 202107 financing round Series C £110m ($153m) co-led by Omega Funds + TCG X 2021-07-27
Artios Pharma–TCG Crossover: investment, 202107 financing round Series C totalling £110m ($153m) incl new + co-lead investor TCG X 2021-07-27
Axa–SEVERAL: investment, 202107 raising of €1.9b equity by AXA IM Alts to invest in European Life Sciences primarly via Kadans Science Partner 2021-07-26
BioLegend–PerkinElmer: investment, 202107– acquisition $5.25b in cash + shares subject to certain adjustments ANNOUNCED 2021-07-26
Relief Therapeutics–SEVERAL: investment, 202107 private placement CHF15m with 71.4m common stock at CHF0.21/share to two US institutional investors 2021-07-26
Voluntis–Aptar: investment, 202106– cash tender offer €78.8m at €8.7/share announced with 64.6% committed by reference shareholders 2021-07-23
Slingshot Biosciences–Anterra Capital: investment, 202107 financing round Series A totalling $23m inc co-investor Anterra Capital 2021-07-22
Slingshot Biosciences–ARCH Venture: investment, 202107 financing round Series A totalling $23m inc co-investor ARCH Venture Partners 2021-07-22
Slingshot Biosciences–Northpond Ventures: investment, 202107 financing round Series A totalling $23m inc lead investor Northpond Ventures 2021-07-22
Slingshot Biosciences–SEVERAL: investment, 202107 financing round Series A $23m led by Northpond Ventures with ARCH Venture Partners + Anterra Capital 2021-07-22
Sophia Genetics–SEVERAL: investment, 202107 US IPO $234m+$35.1m with 13m+1.95m ordinary shares at $18/Share at Nasdaq Global Select Market 2021-07-22
Excellims–Covalent Bonds: public relations, 202107 service existent by Covalent Bonds 2021-07-21
3a-Diagnostics–XPhyto Therapeutics: investment, 202107– 202110 acqisition 100% €400k upfront + €3.5m at closing ANNOUNCED 2021-07-20
Omniome–Pacific Biosciences: investment, 202107– acquisition $300m cash + $600m in shares + $200m milestones in cash + shares ANNOUNCED 2021-07-20
Pacific Biosciences–Casdin Capital: investment, 202107– private placement PIPE totalling $300m incl existing key investor Casdin Capital 2021-07-20
Pacific Biosciences–SEVERAL: investment, 202107– private placement PIPE $300m with 11.2m shares at $26.75/share to key existing investors 2021-07-20
Pacific Biosciences–SoftBank: investment, 202107– private placement PIPE totalling $300m incl existing key investor SoftBank 2021-07-20
Pacific Biosciences–T Rowe Price: investment, 202107– private placement PIPE totalling $300m incl existing key investor T Rowe Price Associates 2021-07-20
Intelligent Tissue Group–BioIVT: investment, 202107 acquisition €na of Tissue Solutions Ltd by BioIVT 2021-07-19
NanoSyrinx–Octopus Ventures: investment, 202107 seed financing round totalling £6.2m incl new + co-lead investor Octopus Ventures 2021-07-19
NanoSyrinx–SEVERAL: investment, 202107 seed financing round £6.2m co-led by Octopus Ventures + M Ventures 2021-07-19
NanoSyrinx–We are Pioneer Group: investment, 202107 seed financing round totalling £6.2m incl existing + co-investor WAPG 2021-07-19
Immunic–SEVERAL: investment, 202107 underwritten public offering $45m with 4.5m shares common stock at $10/share 2021-07-14
Kriya Therapeutics–SEVERAL: investment, 202107 financing round Series B $100m led by Patient Square Capital + incl new + existing investors 2021-07-14
Mobilion–SEVERAL: investment, 202107 financing round Series C $60m led by new investor D1 Capital Partners 2021-07-13
RayzeBio–48Hour Discovery: radiopharmaceuticals, 202107– strategic collab r+d of peptide-based radiopharmaceuticals 2021-07-12
1 2 3 ... 51 52 53  next pagenext page



Advertisement

Picture [iito] No Content Marketing 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

» top